|
|
 | | | |
- close
- close
- close
- close
Idenix Pharmaceuticals (IDIX) |
Benzinga
Apr 8
Comment
Idenix Pharmaceuticals,
Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and
development of drugs for the treatment of human viral diseases, today
announced that it will present data on IDX719, the Company's pan-genotypic...
Benzinga
Mar 25
Comment
In a report published Monday, Bank of America analyst Rachel McMinn downgraded the rating on Idenix Pharmaceuticals (NASDAQ: IDIX) from Neutral to Underperform, and lowered the price target from $7.00 to $3.00.
In the report, McMinn noted,...
Benzinga
Mar 25
Comment
CIFC (NASDAQ: CIFC) dropped 12.67% to $7.10 at 10:13 a.m.
Top Ships (NASDAQ: TOPS) shares dipped 11.20% to $1.19. Top Ships' trailing-twelve-month ROE is -12.37%.
Idenix Pharmaceuticals (NASDAQ: IDIX) fell 11.09% to $4.09 after the company...
StreetInsider.com
Mar 25
Comment
ZaZa Energy Corporation (NASDAQ: ZAZA) 21% HIGHER; entered into a purchase and sale agreement to sell ~10,000 net acres of the Companys properties located in Fayette, Gonzalez and Lavaca Counties, Texas, which the Company refers to as its Moulton...
Wall Street Journal
Mar 25
Comment
Among the companies with shares expected to actively trade in Monday's session are Research In Motion, Idenix Pharmaceuticals and Apollo Group.
TheStreet.com
Mar 25
Comment
CAMBRIDGE, Mass. (TheStreet) -- Idenix Pharmaceuticals shares are weak Monday morning following the loss in the first phase of a hepatitis C patent dispute with Gilead Sciences .
The U.S. Patent and Trademark Office (USPTO) determined that...
StreetInsider.com
Mar 22
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Idenix+Pharma+%28IDIX%29+Receives+Adverse+Decision+in+HCV+Patent+Filing%3B+Will+Appeal/8206923.html for the full story.
Benzinga
Feb 26
Comment
JP Morgan maintained Idenix Pharmaceuticals (NASDAQ: IDIX) with an Overweight and lowers the price target from $15.00 to $13.00.
JP Morgan noted, "Overall, we expect Idenix to make solid pipeline progress in 1H13; however, Idenix is likely to...
StreetInsider.com
Feb 25
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Idenix+Pharmaceuticals+%28IDIX%29+Reports+In-Line+Q4+Loss+of+17cShare/8129651.html for the full story.
TheStreet.com
Feb 12
Comment
BOSTON (TheStreet) -- Ray Dirks posted a screed against Idenix Pharmaceuticals and other hepatitis C drug companies on Seeking Alpha Monday night riddled with factual errors and misstatements. Idenix and other stocks were the foil Dirks used to...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_1/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_1/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
